Intraepidermal nerve fiber density (IENFD)

Intraepidermal nerve fiber density (IENFD) is a quantitative histological measurement used to assess the concentration of small-diameter sensory nerve endings—primarily unmyelinated C-fibers and thinly myelinated A-delta fibers—within the epidermis [5, 9]. It is widely considered the gold standard diagnostic biomarker for small fiber neuropathy (SFN), a condition characterized by damage to these fibers that often eludes detection by standard nerve conduction studies [9, 10]. Measurement is typically performed using a 3-mm skin punch biopsy, followed by immunohistochemical or immunofluorescent staining for the pan-axonal marker Protein Gene Product 9.5 (PGP 9.5) to count fibers crossing the dermal-epidermal junction [5, 10]. A reduction in IENFD is strongly correlated with neuropathic symptoms such as burning pain, paresthesia, and thermal hypersensitivity across a range of conditions including diabetes, chemotherapy-induced toxicity, and idiopathic neuropathies [4, 8]. While IENFD is a pathological metric rather than a specific molecular target, it serves as a critical clinical trial endpoint for evaluating the efficacy of neuroprotective and regenerative drugs [1, 2, 8].

Other names

Epidermal nerve fiber densitySmall fiber densityIENF densityDistal intraepidermal nerve fiber density